Singapore, Singapore

Cho Yeow Koh

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cho Yeow Koh: Innovator in Thrombin Inhibition

Introduction

Cho Yeow Koh is a prominent inventor based in Singapore, known for his significant contributions to the field of thrombin inhibitors. With a total of 2 patents, his work focuses on developing innovative solutions for medical applications.

Latest Patents

His latest patents include groundbreaking inventions related to thrombin inhibitors. The first patent provides isolated peptides, variants, and fragments that can bind with high specificity to thrombin, effectively inhibiting its activity. This invention also outlines the uses of such peptides in diagnostic and treatment methods, as well as in the coating of medical devices and nucleic acids encoding the same. The second patent relates to thrombin inhibitors derived from the salivary glands of haematophagous arthropods, specifically focusing on bivalent and trivalent thrombin inhibitors that interact with thrombin at multiple sites.

Career Highlights

Throughout his career, Cho Yeow Koh has worked with notable organizations, including Isis Innovation Limited and the National University of Singapore. His experience in these institutions has contributed to his expertise in the field of thrombin inhibition.

Collaborations

He has collaborated with esteemed colleagues such as R Manjunatha Kini and Maria Kazimtrova, further enhancing the impact of his research and innovations.

Conclusion

Cho Yeow Koh's work in thrombin inhibitors showcases his dedication to advancing medical science through innovative inventions. His contributions are significant in the realm of medical diagnostics and treatment, making him a noteworthy figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…